Quris AI

Company Deals

Merck KGaA Adopts Quris AI’s Bio-AI Platform for Drug Development Pipeline

Fineline Cube Jan 8, 2025

Quris AI, an artificial intelligence (AI) pharmaceutical company based in Boston and Tel-Aviv, has announced...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod